ロード中...
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
BACKGROUND: Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTPEH). The objective of this study was to evaluate right heart size and function assessed by echocardiography during long term treatm...
保存先:
| 出版年: | Respir Res |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299931/ https://ncbi.nlm.nih.gov/pubmed/30567595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-018-0957-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|